Lam Research Corporation LRCX shares are trading lower by 6.5% to $776.07 during Friday’s session. Shares of semiconductor stocks are declining in response to Intel Corp’s weaker-than-expected second-quarter financial results.
Intel shares are down some 27% Friday morning following disappointing second-quarter results and the announcement of a 15% workforce reduction and dividend suspension.
This slump is part of Intel's broader struggle to compete with leading chipmakers like Taiwan Semiconductor Mfg. Co. Ltd. and if the losses persist, the company's market capitalization could drop to about $100 billion.
Read Also: What’s Going On With Amazon Stock After Earnings?
Why This Matters To LRCX Investors
Intel is one of the largest semiconductor manufacturers, and it is a significant customer for many suppliers in the semiconductor industry, including Lam Research. A substantial decline in Intel's profitability or a reduction in its capital expenditure could lead to a decrease in orders from Intel. This could impact Lam Research's revenue and potentially its profitability.
Intel’s financial strain could raise concerns about the financial health of its suppliers and partners. If Intel is experiencing difficulties, investors might worry that other companies in its supply chain, including Lam Research, could also face financial stress or reduced business opportunities.
How To Buy LRCX Stock
Besides going to a brokerage platform to purchase a share – or fractional share – of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.
For example, in Lam Research’s case, it is in the Information Technology sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
According to data from Benzinga Pro, LRCX has a 52-week high of $1,130.00 and a 52-week low of $574.42.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.